Single Dose Safety, Tolerability and Pharmacokinetic Study of NCTX in Healthy Volunteers
Phase 1
Terminated
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Saline PlaceboDrug: NCTX (PEGylated Liposomal Iodixanol Injection)
- First Posted Date
- 2014-02-14
- Last Posted Date
- 2014-10-10
- Lead Sponsor
- Marval Pharma Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT02063594
- Locations
- 🇺🇸
Quintiles Phase 1 Services, Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath